Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study.

The Journal of clinical endocrinology and metabolism - 13 Jul 2021

Tremblay Maxime, Perrot Nicolas, Ghodsian Nooshin, Gobeil Émilie, Couture Christian, Mitchell Patricia L, Thériault Sébastien, Arsenault Benoit J

Abstract excerpt

CONTEXT: The impact of galectin-3 inhibitors on nonalcoholic fatty liver diseases (NAFLD)-related outcomes is currently under investigation in randomized clinical trials. Whether there is a causal association between plasma galectin-3 levels and NAFLD is unknown. OBJECTIVE: To evaluate the causal effect of circulating galectin-3 levels on NAFLD as well as >800 other human diseases. DESIGN: Inverse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Galectin 3

Share to Gene Frequency

Share to Mendelian Randomization Analysis

Share to Non-alcoholic Fatty Liver Disease

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 33693708
DOI: 10.1210/clinem/dgab144

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study.PMID 33693708Read ↗

Serum 25-hydroxyvitamin D levels and the risk of non-alcoholic fatty liver: A two-sample Mendelian randomization study.Semantic proximity Read ↗

Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization AnalysisSemantic proximity Read ↗

Mendelian Randomization Analysis Dissects the Relationship between NAFLD, T2D, and Obesity and Provides Implications to Precision MedicineSemantic proximity Read ↗

Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study.Semantic proximity Read ↗

Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization studySemantic proximity Read ↗

Causal relationships between three plasma proteins and non-alcoholic fatty liver disease, mediated by Epstein-Barr virus EA-D antibody levels: a mendelian randomization study.Semantic proximity Read ↗

PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis.Semantic proximity Read ↗

Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study.Semantic proximity Read ↗

Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study.Semantic proximity Read ↗

Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study.Semantic proximity Read ↗

Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization studySemantic proximity Read ↗

Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.